3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Lung Neoplasms
19
Small Cell Lung Carcinoma
16
Mesothelioma, Malignant
7
Adenocarcinoma of Lung
7
Ovarian Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Recurrence
2
Non-squamous Non-small Cell Lung Cancer
2
NSCLC
2
Brain Neoplasms
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Cancer Extensive Stage
1
SCLC
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Penile Neoplasms
1
Pelvic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Non-squamous NSCLC
1
Non-small Cell Lung Cancer Metastatic
1
Mesothelioma
1
Liposarcoma
1
Gallbladder Neoplasms
1
Interventions
sargramostim
1
oblimersen
1
entinostat
1
atezolizumab
1
Ritonavir
1
Radiotherapy
1
Platinum
1
Nivolumab
1
Indinavir
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Drug Therapy
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Platinum
×
Thoracic
×
Clear all
NCT05765084
2024-05-16
Immuno-MESODEC
University Hospital, Antwerp
Phase 1/2
Recruiting
15 enrolled